171 related articles for article (PubMed ID: 31355024)
1. Partial and Transient Clinical Response to Omalizumab in IL-21-Induced Low STAT3-Phosphorylation on Hyper-IgE Syndrome.
Alonso-Bello CD; Jiménez-Martínez MDC; Vargas-Camaño ME; Hierro-Orozco S; Ynga-Durand MA; Berrón-Ruiz L; Alcántara-Montiel JC; Santos-Argumedo L; Herrera-Sánchez DA; Lozano-Patiño F; Castrejón-Vázquez MI
Case Reports Immunol; 2019; 2019():6357256. PubMed ID: 31355024
[TBL] [Abstract][Full Text] [Related]
2. Omalizumab for STAT3 Hyper-IgE Syndromes in Adulthood: A Case Report and Literature Review.
Lan J; Zhang Y; Song M; Cai S; Luo H; OuYang R; Yang P; Shi X; Long Y; Chen Y
Front Med (Lausanne); 2022; 9():835257. PubMed ID: 35602476
[TBL] [Abstract][Full Text] [Related]
3. Atopic dermatitis or hyper-IgE syndrome?
Ohameje NU; Loveless JW; Saini SS
Allergy Asthma Proc; 2006; 27(3):289-91. PubMed ID: 16913276
[TBL] [Abstract][Full Text] [Related]
4. Role of omalizumab in a patient with hyper-IgE syndrome and review dermatologic manifestations.
Chularojanamontri L; Wimoolchart S; Tuchinda P; Kulthanan K; Kiewjoy N
Asian Pac J Allergy Immunol; 2009 Dec; 27(4):233-6. PubMed ID: 20232578
[TBL] [Abstract][Full Text] [Related]
5. The treatment efficacy of dupilumab in autosomal dominant hyper-immunoglobulin E syndrome with severe atopic dermatitis.
Li W; Qi Q; Wang W; Li D
Asia Pac Allergy; 2024 Mar; 14(1):39-41. PubMed ID: 38482457
[TBL] [Abstract][Full Text] [Related]
6. Hyper IgE Syndromes.
Gracci S; Novelli T; D'Elios S; Bernardini R; Peroni D
Curr Pediatr Rev; 2024; 20(3):253-264. PubMed ID: 37702167
[TBL] [Abstract][Full Text] [Related]
7. Clearance of atypical cutaneous manifestations of hyper-IgE syndrome with dupilumab.
Nihal A; Comstock JR; Holland KE; Singh AM; Seroogy CM; Arkin LM
Pediatr Dermatol; 2022 Nov; 39(6):940-942. PubMed ID: 35734823
[TBL] [Abstract][Full Text] [Related]
8. Atopic dermatitis, STAT3- and DOCK8-hyper-IgE syndromes differ in IgE-based sensitization pattern.
Boos AC; Hagl B; Schlesinger A; Halm BE; Ballenberger N; Pinarci M; Heinz V; Kreilinger D; Spielberger BD; Schimke-Marques LF; Sawalle-Belohradsky J; Belohradsky BH; Przybilla B; Schaub B; Wollenberg A; Renner ED
Allergy; 2014 Jul; 69(7):943-53. PubMed ID: 24898675
[TBL] [Abstract][Full Text] [Related]
9. Hyper-Immunoglobulin E (IgE) Syndrome: A Diagnostic Dilemma.
Tejada Amaro O; Oboli VN; Kumar S
Cureus; 2023 Jul; 15(7):e42729. PubMed ID: 37529815
[TBL] [Abstract][Full Text] [Related]
10. [Hyper-IgE syndrome with mutation in STAT3 gene - case report and literature review].
Heropolitańska-Pliszka E; Pietrucha B; Mikołuć B; Bernatowska E
Med Wieku Rozwoj; 2009; 13(1):19-25. PubMed ID: 19648655
[TBL] [Abstract][Full Text] [Related]
11. Hyper-IgE syndrome: a case report.
Dave T; Tashrifwala FAA; Rangwala US; Hameed R
Ann Med Surg (Lond); 2024 Feb; 86(2):1205-1209. PubMed ID: 38333292
[TBL] [Abstract][Full Text] [Related]
12. Elevated serum immunoglobulin E (IgE): when to suspect hyper-IgE syndrome-A 10-year pediatric tertiary care center experience.
Joshi AY; Iyer VN; Boyce TG; Hagan JB; Park MA; Abraham RS
Allergy Asthma Proc; 2009; 30(1):23-7. PubMed ID: 19331717
[TBL] [Abstract][Full Text] [Related]
13. Autosomal-Recessive Hyper-IgE Syndrome.
Liza M; Gaurav D; Prasenjeet M; Swapna J; Binodini B
Indian J Dermatol; 2018; 63(1):79-81. PubMed ID: 29527033
[TBL] [Abstract][Full Text] [Related]
14. Recurrent Skin and Lung Infections in Autosomal Dominant Hyper IgE Syndrome with Transactivation Domain STAT3 Mutation.
Cooper CJ; Said S; Hernandez GT
Case Reports Immunol; 2014; 2014():136752. PubMed ID: 25379309
[TBL] [Abstract][Full Text] [Related]
15. Hyper IgE syndrome.
Dang Y; Ren J; Guo Y; Geng S
Indian Dermatol Online J; 2014 Jan; 5(1):69-71. PubMed ID: 24616862
[TBL] [Abstract][Full Text] [Related]
16. Dupilumab for STAT3-Hyper-IgE Syndrome With Refractory Intestinal Complication.
Lu CW; Lee WI; Chung WH
Pediatrics; 2021 Sep; 148(3):. PubMed ID: 34417287
[TBL] [Abstract][Full Text] [Related]
17. Impaired memory B-cell development and antibody maturation with a skewing toward IgE in patients with STAT3 hyper-IgE syndrome.
van de Veen W; Krätz CE; McKenzie CI; Aui PM; Neumann J; van Noesel CJM; Wirz OF; Hagl B; Kröner C; Spielberger BD; Akdis CA; van Zelm MC; Akdis M; Renner ED
Allergy; 2019 Dec; 74(12):2394-2405. PubMed ID: 31269238
[TBL] [Abstract][Full Text] [Related]
18.
Park B; Liu GY
Int J Mol Sci; 2020 Dec; 21(23):. PubMed ID: 33271763
[TBL] [Abstract][Full Text] [Related]
19. Pediatric hyperimmunoglobulin E syndrome (Job's syndrome) with STAT3 mutation: A case report.
Bhutani N; Sharma U; Kumar A; Kajal P
Ann Med Surg (Lond); 2021 Jun; 66():102452. PubMed ID: 34141423
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
